Vaccinations have been shown repeatedly to be extremely safe with low incidence of complications. Given the rarity, these adverse events, they must be reported and examined cautiously. This case report illustrates the first case of an adult presenting with Wells syndrome 
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2 that developed soon after vaccination with the thiomersal, a common preservative, containing influenza vaccine. Wells syndrome, also known as eosinophilic cellulitis, is an uncommon dermatologic condition of unknown etiology. Lesions in patients with Wells syndrome (eosinophilic cellulitis) progress over a few days to become large indurated plaques with associated edema and erythema. Although the etiology of Wells syndrome remains unknown, certain precipitants have been described in the literature, including but not limited to parasitic infections, contact dermatitis, Churg-Strauss disease and various medications. This article describes a possible sensitivity to thiomersal, as well as describes other cases that have reported a similar sensitivity secondary to receiving thiomersal-containing vaccines. 
INTRODUCTION:
Vaccinations have been shown repeatedly to be extremely safe with low incidence of complications. One study performed by Weisser et al. highlight vaccination trials boasting an adverse event ratio frequency of 1:1,000 to 1:10,000 individuals 1 . Given the rarity, these adverse events, they must be reported and examined cautiously. One of the possible manifestations is skin disease, such as reported secondary to the influenza vaccination as seen this case report. 
DISCUSSION:
Wells syndrome is a rare condition, only being first described in 1971. Table 1) . The current case presented fits the proposed diagnostic criteria and achieved full resolution after a course of oral steroids. The current case was diagnosed given the major criteria: (1) not caused by systemic disease (2) the histiology of eosinophillic infiltrates (3) the papulonodular type dermatologic manifestation. Additionally, the minor criteria being that developed soon after a drug, in this case the influenza vaccination.
Although this is the first case described of an adult presenting with Wells syndrome after receiving the influenza vaccination, there have been two cases of children being diagnosed with Wells syndrome post-influenza vaccination and one case of an adult being diagnosed after [5] [6] [7] . Indeed, all the vaccinations described in the literature along with the influenza vaccination received in this case include thiomersal, a common preservative.
In the case of the patient with Wells syndrome post-tetanus vaccination, a skin test with thiomersal was found to be positive, demonstrating the possibility that part of the pathophysiology of Wells is related to hypersensitivity reactions. 6 The patient in this study did opt for a skin test that will allow confirmation of the thiomersal hypersensitivity.
This case illustrates the first patient who presented with clinical Wells syndrome after receiving the thiomersal-containing influenza vaccination. This stresses the importance for clinicians to obtain a complete drug history (including vaccination) when a patient presents with a rash of unknown etiology. Additionally, clinicians must be aware of the possible sensitivity to thiomersal when a patient presents with a possibly unknown drug reaction. 
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